Marseille

• A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythema … Pending
  2025-523670-17-00 5 Systemic lupus erythematosus
• Skipping Hormone Therapy in Low-Risk Early Breast Cancer Pending
  2025-523683-20-00 4 Postmenopausal patients with small (pT1a-b pN0) hormone receptor posit
• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat … Pending
  2025-523735-19-00 5 Metastatic Microsatellite Stable Colorectal Cancer
• Efficacy and safety of vamifeport in adult subjects with HFE-related hereditary hemochromatosis Pending
  2025-523793-16-00 4 Homeostatic iron regulator gene-related hereditary hemochromatosis
• Comparison of weekly Somatrogon to daily Genotropin in children born small for gestational age or with idiopathic short stature. Pending
  2025-523832-38-00 5 Small for gestational age (SGA) and idiopathic short stature (ISS)
• Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome Pending
  2025-523835-20-00 7 Dravet Syndrome
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors Pending
  2025-523895-22-00 4 Non-small cell lung cancer (NSCLC)
• Liver-directed chemotherapy after surgery of liver metastases of colorectal cancer in patients with high risk of recurrence of their disease … Pending
  2025-523913-27-00 5 Participants with R0/R1 resected liver metastases from colorectal canc
• Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults with Advanced Colorectal Cancer. Pending
  2025-523984-39-00 4 Advanced Microsatellite Stable (MSS) Colorectal Cancer (CRC)
• TAR-0520 gel in Hand and Foot Syndrome Pending
  2025-524008-32-00 4 Capecitabine-induced hand and foot syndrome
• Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ … Pending
  2025-524095-27-00 4 HER2-negative, unresectable, recurrent, and/or metastatic gastric, GEJ
• A study of cemsidomide and dexamethasone in subjects with relapsed or refractory multiple myeloma (r/r MM) Pending
  2025-524181-26-00 4 relapsed/refractory multiple myeloma
• TAILORswitch (PADA-2): rising ctDNA to tailor endocrine therapy switch in patients with ER+/HER2- metastatic breast cancer. Pending
  2025-524213-84-00 5 Patients with advanced or metastatic ER+ HER2- breast cancer
• REGENOVAR: A Phase I/II Study of Ubamatamab Plus Carboplatin, Paclitaxel, and Bevacizumab as Salvage Therapy in Ovarian Cancer with Poor Res … Pending
  2025-524232-20-00 7 Patients with poor prognostic ovarian cancers based on the tumor prima
• BETRI-Prospective: Asthma control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 µg]) vs Single Inhaler ICS/LABA (200/ … Pending
  2025-524289-56-00 6 Asthma
• Open-Label Extension Study to Provide Access to ATH434 in Patients with Multiple System Atrophy Pending
  2025-524317-88-00 4 Multiple System Atrophy
• Immunogenicity and safety of two respiratory syncytial virus vaccine strategies in lung and allogeneic haematopoietic stem cell transplant r … Pending
  2025-524374-42-00 4 allogeneic haematopoietic stem cell transplant recipient
• An experimental trial to learn about hu14.18K322A treatment in children and adolescents with high-risk neuroblastoma. Pending
  2025-524397-42-00 10 Participants with relapsed HRNB and participants with HRNB refractory
• Real-world study to evaluate how effective and safe Pegcetacoplan is in patients with rare kidney diseases called C3G or IC-MPGN in multiple … Pending
  2025-524487-37-00 6 Primary Immune Complex Membranoproliferative Glomerulonephritis (IC-MP
• A Research Study Testing New Cancer Medicines Used Alone or Together to Treat Solid Tumors Pending
  2025-524623-50-00 9 Solid Tumors
• Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combination for Inflammatory Bowel Disease Pending
  2025-524640-35-00 4 Ulcerative colitis (Inflammatory Bowel Disease)
• Symbiotic-Lung-14: A Study to Learn About the Study Medicine called PF-08634404 in Combination With Chemotherapy in Adult Participants With … Pending
  2025-524686-24-00 4 Small Cell Lung Cancer
• Open-label study of BBO-11818 in adult subjects with KRAS mutant cancer Pending
  2025-524690-16-00 1 Solid Tumors

Showing 121–144 of 1,519 trials